WinstonWınston
Back
Neola Medical AB (publ) logo

Neola Medical AB (publ)

NEOLA.ST
Medical - Devices · Healthcare
Exchange
Stockholm Stock Exchange
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Winston Score History

The full picture

Neola Medical AB is a Swedish medical device company focused on monitoring the health of premature babies. Its core product is the NEOLA system, a non-invasive device that continuously monitors lung health in newborns using a technology called electrical impedance tomography. The main customers are neonatal intensive care units (NICUs) in hospitals.

The company earns revenue by selling its monitoring hardware and related consumables to hospitals, though it is still in an early commercial stage and currently generates little to no meaningful revenue. Neola Medical operates primarily in Europe, with a small market capitalization of around $100 million, reflecting its pre-revenue status. The key growth driver is gaining regulatory approvals and clinical adoption across more hospitals, but the main risk is that the company continues to burn cash without a clear path to profitability, which is common for early-stage medical device firms.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

-23.8% YoY

YoY Growth Rate

Earnings declining

Insider Activity

70.2%ownership

Rising

Insiders increasing their stake — aligned with shareholders

Cash Runway

~5 months

kr 10M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Neola Medical AB (publ) has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
N/A
Data not available
Profit after running costs
Operating Margin
N/A
Data not available
Return on the money invested
ROCE
-16.6%
Weak — -16.6% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
N/A
Data not available
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
no trend
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial